Stay up to date on ASPREE news and events


Video and Audio

2023 ASPREE online study update

Earlier this year, members of the ASPREE team in Australia and the US contributed to three online study updates.  This video is a compilation of all of webinars and gives an overview of project aims and progress, including future plans and answers frequently asked questions.

Hear from Brenda Kirpach, who is Director of ASPREE in the US, as well as from research investigators and GPs, Prof Mark Nelson (TAS) and Prof Nigel Stocks (SA).

To find more information about topics covered in the webinar follow these links:  about our team, about ASPREE findings and FAQs; about ASPREE sub-studies; the location of study centres; published scientific papers that used ASPREE data; and ASPREE project research news and stories.



Enjoy watching a few videos created during the ASPREE project – from its launch, to media interest, to several special Australians who supported the project.


Summary of ASPREE Clinical Trial Findings (September, 2018)


Community Service Announcements (CSA)

Ita Buttrose and Gus Nossal lent their support to the ASPREE project by featuring in several CSAs. Our thanks extends to Australian TV networks that aired the CSAs about the public good study.



Ita Buttrose

  • ASPREE 30 second Community Service Announcement featuring Australian of the Year, Ita Buttrose (2015)
ASPREE 15 second Community Service Announcement featuring Ita Buttrose (2015)

Gus Nossal

ASPREE 30 second Community Service Announcement featuring Sir Gus Nossal (2012-2013)

ASPREE 15 second Community Service Announcement featuring Sir Gus Nossal (2012-2013)

Study updates and centre launches

ASPREE Study Update in Mildura (August, 2014)

ASPREE Study Update in Bendigo (June, 2014)

Launch of Wollongong Clinical Trial Centre (October 2013)

ASPREE Study Update in Albury (August, 2013)

ASPREE Study Update in Bendigo (May, 2012)

SBS World News (March, 2012)

Official launch of the ASPREE Clinical Trial (2009)

Please note, ASPREE contact details in this video are outdated. Our website is and our contact phone number is 1800 728 745.


Read the latest project developments and progress, or search ASPREE news and events posts here.
Example of ASPREE News Posts
Above: An example of posts to keep you informed of ASPREE project progress and research outcomes. Click on the link above the image to read our latest news.


The ASPREE project produces and contributes to a number of publications for a range of audiences.

Biannual ASPREE newsletters are sent to ASPREE-XT study participants, providing an easy to read update on research progress, major developments, publications and findings.

Project updates geared towards the medical community are sent to GPs and practices with patients in the study.  Reseachers involved in the ASPREE project, or with an interest in the research, are updated on developments and outcomes by the Principal Investigators.


ASPREE holds informal presentations (study updates) for participants and GPs at various study site locations in south-eastern Australia. The presentation brings attendees and guests up to date on the progress of the research, accomplishments, new developments, such as new sub-studies, and explains published findings. These events provide an opportunity for participants to ask questions and share a cuppa afterwards (see photos below).

Research investigators frequently share study findings at professional conferences nationally and internationally, driving advancements in knowledge in health and ageing.

Pictured above: Guests attending an ASPREE  ‘study update’ presentation and sharing light refreshements afterwards at Clayton, Melbourne.


ASPREE project (including sub-study) findings are shared with scientists, physicians, doctors and researchers worldwide via publication in quality medical journals.

ASPREE investigators frequently contribute to specialist and broader media articles.


Downloable brochures to explain both components of ASPREE research: the clinical trial and the follow-up longitudinal study.


Journalists and writers who would like to know more about the ASPREE project or arrange an interview with key investigators on the project, should contact:

Trish Nichols

Ph: (+61) 3 9903 0103  E:

Contact us

Participant, GP and general enquiries

Ph: 1800 728 745 (free call from a landline)
Operating 9am-5pm weekdays (we will return missed calls)

ASPREE National Co-ordinating Centre,
School of Public Health and Preventive Medicine, Monash University
Level 2, 553 St.Kilda Road, Melbourne 3004

Page updated: 2 August 2023


Aspirin and anaemia risk in older adults
Aspirin and anaemia risk in older adults

A new analysis of ASPREE trial data has found that prolonged daily aspirin use increases the risk of anaemia in some older adults. Findings from ASPREE-Anaemia, a sub-study of the ASPREE trial, may help GPs identify older patients at higher risk of anaemia and who may benefit from regular monitoring for development of the condition.

Poor gait/handgrip linked to dementia risk
Poor gait/handgrip linked to dementia risk

Walking speed and grip strength could be early indicators of dementia before the onset of noticeable symptoms, new findings from the ASPREE trial reveals. Researchers found slow walking speed combined with weak hand grip was a stronger predictor of cognitive decline and dementia in older adults than either measure alone.

News resources and media